Bioventix (LON:BVXP) Stock Passes Below 200 Day Moving Average – Here’s What Happened

Shares of Bioventix PLC (LON:BVXPGet Free Report) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 3,865.74 ($47.03) and traded as low as GBX 3,050 ($37.11). Bioventix shares last traded at GBX 3,250 ($39.54), with a volume of 4,369 shares.

Bioventix Price Performance

The company’s 50 day moving average price is GBX 3,492.52 and its 200 day moving average price is GBX 3,853.63. The firm has a market capitalization of £164.68 million, a P/E ratio of 1,935.41 and a beta of 0.35.

Bioventix Increases Dividend

The company also recently announced a dividend, which was paid on Thursday, November 21st. Stockholders of record on Thursday, November 7th were given a dividend of GBX 87 ($1.06) per share. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 2.4%. This is an increase from Bioventix’s previous dividend of $68.00. Bioventix’s payout ratio is presently 9,693.25%.

Insider Activity at Bioventix

In related news, insider Bruce Hiscock purchased 24 shares of Bioventix stock in a transaction dated Friday, November 22nd. The shares were acquired at an average cost of GBX 3,822 ($46.50) per share, for a total transaction of £917.28 ($1,116.05). Insiders have bought a total of 385 shares of company stock worth $1,107,381 over the last 90 days. Insiders own 8.02% of the company’s stock.

Bioventix Company Profile

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

See Also

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.